Jiangnan Mould & Plastic Technology reduced its shareholding in Bank Of Jiangsu by 25 million shares, and multiple listed banks have seen shareholding reductions by shareholders this year.

① On the evening of December 11, the listed company Jiangnan Mould & Plastic Technology (000700) announced that it had recently reduced its shareholding in Bank Of Jiangsu by 25 million shares, with a transaction amount of 0.226 billion yuan. ② Throughout the year, there have been multiple cases where shares of listed banks have been reduced by Shareholders, involving Bank Of Changsha, Bank Of Hangzhou, Qilu Bank, and others.

cls.cn01:16 ET

Not recognized by the capital markets? Guangxi Liuyao Group: The company's stock price does not match its value | Direct coverage of the earnings conference.

1. At the earnings conference, the chairman of guangxi liuyao group, Zhu Chaoyang, stated that the company's market cap, stock price, and company value are not aligned; 2. The company secretary Xu Yang stated that the company will improve the issue of high accounts receivable through measures such as strengthening the assessment of collection indicators for business personnel; 3. Xu Yang introduced the progress of the company's AI application business in response to investors' concerns.

cls.cnDec 9 07:31 ET

How do domestic semiconductors industry chain grow against the wind? At this closed-door event, many "little giant" companies shared their insights and advice.

① The release of a new round of export control entity lists has fostered the consensus within the industry to cultivate and develop a domestic supply chain system. ② Several emerging companies in the semiconductors field recently stated at an industry event that the domestic market for semiconductor equipment and memory chips is vast, and small and medium-sized enterprises possess the resilience for growth and development.

cls.cnDec 5 21:39 ET

henan lingrui pharmaceutical plans to acquire Silver Valley Pharmaceuticals for 0.782 billion. Traditional Chinese medicine patch and plaster leading the cross-border pharmaceutical market | Quick reading announcement

①Henan Lingrui Pharmaceutical intends to acquire all the equity of Silver Valley Pharmaceutical for 0.782 billion yuan, entering the market of innovative drugs in chemical medicine. ②According to Mononucleosis Medical Data, Silver Valley Pharmaceutical's sales in 2023 exceeded 0.4 billion yuan, with the top-selling product being Jin'erli, accounting for about 70% of the company's total revenue, and the growth rate of Class 1 new drug Biti Cong quickly. ③If the acquisition of Silver Valley Pharmaceutical proceeds smoothly, the company's previously set stock-based incentive unlocking target may be difficult to achieve or significantly reduced.

cls.cnDec 4 10:07 ET

Intense competition in CRO has reduced gross margin. Sunlight Nuohe is entering the animal health field to seek new growth points.

① Sunshine Nuohuo has experienced growth in revenue and net income in the first three quarters of this year compared to previous years, but intense competition in the industry has led to a decline in gross margin, and the chairman revealed that the company is increasing its investment in research and development. ② To seek new growth points, Sunshine Nuohuo is expanding its CRO business from the human pharmaceutical field to the animal health field by establishing subsidiaries, and has signed service orders with several medium and large animal pharmaceutical companies.

cls.cnDec 2 02:59 ET

The first A-share company to complete a repurchase using special loans! This week, deppon logistics and 14 other stocks disclosed repurchase and shareholding refinancing plans. Here is a list of the relevant A-share companies.

① Recently, A-share companies that have obtained repurchase and shareholding loan support continue to expand. According to incomplete statistics from Caixin, this week 14 A-share listed companies have announced the disclosure of repurchase and shareholding refinancing situations (see table); ② Deppon Logistics plans to increase its shareholding by 0.3 billion yuan to -0.6 billion yuan and the loan amount will not exceed 0.4 billion yuan. Fushun Special Steel is the first A-share company to disclose the use of own funds and repurchase special loans to complete the repurchase.

cls.cnNov 30 02:21 ET